Abstract |
Efalizumab-associated papular psoriasis is a common adverse event caused by efelizumab therapy. This clinical manifestation is characterized by a transient popular eruption localized especially on the flexural areas and on the back. We report three cases of efalizumab-associated papular psoriasis.
|
Authors | Angela Antonucci, Federico Bardazzi, Riccardo Balestri, Annalisa Patrizi |
Journal | The Journal of dermatological treatment
(J Dermatolog Treat)
Vol. 20
Issue 1
Pg. 61-2
( 2009)
ISSN: 1471-1753 [Electronic] England |
PMID | 18618361
(Publication Type: Journal Article)
|
Chemical References |
- Adrenal Cortex Hormones
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- efalizumab
|
Topics |
- Adrenal Cortex Hormones
(therapeutic use)
- Adult
- Antibodies, Monoclonal
(adverse effects, therapeutic use)
- Antibodies, Monoclonal, Humanized
- Axilla
- Biopsy, Needle
- Dose-Response Relationship, Drug
- Drug Eruptions
(drug therapy, etiology, pathology)
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Male
- Middle Aged
- Psoriasis
(chemically induced, drug therapy, pathology)
- Risk Assessment
- Sampling Studies
|